Skip to Main Content

WASHINGTON — Democrats’ drug pricing law will still penalize drugmakers if they hike prices on medicines for patients who have private insurance, a top Medicare official said Thursday. 

The penalties may factor into drugmakers’ decisions about how to price their medicines as the new law begins to take effect. Some experts and employers have been concerned that the drug pricing policy reforms that will save money in Medicare could incentivize drugmakers to try to charge more to patients with other forms of insurance coverage. 

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment